Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine.
about
Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSnScreening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra-high-performance liquid chromatography with TOF-MS with data-independent acquisition.Development of the first metabolite-based LC-MS(n) urine drug screening procedure-exemplified for antidepressants.Towards a universal LC-MS screening procedure - can an LIT LC-MS(n) screening approach and reference library be used on a quadrupole-LIT hybrid instrument?Comprehensive chemical profiling of guizhi fuling capsule by the combined use of gas chromatography-mass spectrometry with a deconvolution software and rapid-resolution liquid chromatography quadrupole time-of-flight tandem mass spectrometry.New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine.2-methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques.The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC-MS, LC-MSn, and LC-HR-MSn.Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MS(n) techniques.Lefetamine, a controlled drug and pharmaceutical lead of new designer drugs: synthesis, metabolism, and detectability in urine and human liver preparations using GC-MS, LC-MS(n), and LC-high resolution-MS/MS.Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP).Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MSn , and LC-HR-MSn.Clinical Validation of a Highly Sensitive GC-MS Platform for Routine Urine Drug Screening and Real-Time Reporting of up to 212 Drugs.AMDIS in the Chemical Weapons Convention.Systematic forensic toxicological analysis by GC-MS in serum using automated mass spectral deconvolution and identification system.Broad Screening and Identification of Novel Psychoactive Substances in Plasma by High-Performance Liquid Chromatography-High-Resolution Mass Spectrometry and Post-run Library Matching.Power of Orbitrap-based LC-high resolution-MS/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MSn or GC-MS procedures.New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, "LC-(High Resolution)-MSn" and "Navigating freely-available software tools for metabolomics analysis.Synchronized Analysis of FTIR Spectra and GCMS Chromatograms for Evaluation of the Thermally Degraded Vegetable Oils.Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MS.GC-MS, LC-MS(n), LC-high resolution-MS(n), and NMR studies on the metabolism and toxicological detection of mesembrine and mesembrenone, the main alkaloids of the legal high "Kanna" isolated from Sceletium tortuosum.Cancer breath testing: a patent review.Dimethocaine, a synthetic cocaine analogue: studies on its in-vivo metabolism and its detectability in urine by means of a rat model and liquid chromatography-linear ion-trap (high-resolution) mass spectrometry.A multi-analyte approach to help in assessing the severity of acute poisonings - Development and validation of a fast LC-MS/MS quantification approach for 45 drugs and their relevant metabolites with one-point calibration.Metabolic fate of desomorphine elucidated using rat urine, pooled human liver preparations, and human hepatocyte cultures as well as its detectability using standard urine screening approaches.Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MSn.Rapid Identification of Synthetic Cannabinoids in Herbal Incenses with DART-MS and NMR.Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MSn, and LC-HR-MS/MS.Current Challenges in Plant Eco-Metabolomics.Metabolic Profiling of Dendrobium officinale in Response to Precursors and Methyl Jasmonate.
P2860
Q28292983-CA50B478-2C1C-47A9-BD47-FC96B4D91616Q30619552-E6C4583F-D250-4314-9398-7307C883C4F1Q30992027-95013EAE-A68A-4003-ADEF-F212A127EBF1Q34142688-787051C0-6564-4A63-8EA6-C9EC20084C0CQ34148653-D2E5AA5A-A687-4F8B-9F93-CB1B667A39D5Q34167745-25808863-F42E-4A37-ADEA-C75226FDD7AFQ34325128-8F750F96-7832-46AC-B1E1-986A3C5FBE57Q34377572-CE98094D-1AF9-4719-93A4-DBE4A155717BQ34378886-649F3CC3-7517-416D-B0B5-113675A408F2Q34408021-33BA8CFC-06D2-44C0-A125-F91ACA9DF28AQ34451894-9A63EC6D-6DA9-4CAE-AD82-0EFA5289530EQ34457560-937EF9BF-E882-41A8-A818-CD6ED780C848Q34490537-1BC524BE-2EEE-41C1-958C-D9E91788C98FQ34497670-19BF1947-ECA2-4190-B0E8-4998E5FBE6D8Q34510789-494C819A-BD1D-44EF-8C68-48ABB3A0C4BFQ34917423-E378A1E3-87C5-4D6F-A35D-0A4CDB548D6CQ35113531-D68034B6-9C7A-4F79-9689-8F932C936D59Q35762678-414F424B-7EFE-4295-9BD6-21C462C77AAFQ36088120-03B5A185-2D64-4ED5-B537-FA0370810DCAQ38654007-8088CC0D-4071-44AE-908F-4D1933EB36BDQ39272650-864A1009-4B7C-4A33-8E2B-23A0E7B852C0Q41332699-C711B42E-C446-4D0C-A113-4FC2AFC0E606Q41921959-B31F5FA1-1216-4C89-BD58-D20B659EA857Q44806049-F14B7C02-19C4-4A86-9D33-0AD5EE49DD57Q46836046-AEEBA9D0-E25F-4C98-8491-8E8F43A890CFQ47215088-74D23A75-4A43-4C78-98A1-A02823D37619Q47921568-FC54D4D2-A1C5-4D0D-8280-5DDD5BA5BDB7Q48289328-25B670CA-2F18-41BE-BB9B-57D3C661B3F5Q51271242-36881E6A-A7FE-4EC9-814B-15E7085CF481Q52303950-B584D399-208D-4D59-9062-912A0FB842AAQ53364446-50402BE9-80A0-41CE-A988-9F0328315514Q53641072-763A0A60-F863-43E1-952D-1A3C6F9AA240Q55284839-82AE5997-F262-4878-A8AE-EA4F11E0D0B1Q55395909-F67817EF-F0F9-437B-95B4-0B6F862A5F2A
P2860
Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Automated mass spectral deconv ...... ons, and metabolites in urine.
@ast
Automated mass spectral deconv ...... ons, and metabolites in urine.
@en
Automated mass spectral deconv ...... ons, and metabolites in urine.
@nl
type
label
Automated mass spectral deconv ...... ons, and metabolites in urine.
@ast
Automated mass spectral deconv ...... ons, and metabolites in urine.
@en
Automated mass spectral deconv ...... ons, and metabolites in urine.
@nl
prefLabel
Automated mass spectral deconv ...... ons, and metabolites in urine.
@ast
Automated mass spectral deconv ...... ons, and metabolites in urine.
@en
Automated mass spectral deconv ...... ons, and metabolites in urine.
@nl
P921
P1433
P1476
Automated mass spectral deconv ...... ons, and metabolites in urine.
@en
P2093
Frank T Peters
Markus R Meyer
P304
P356
10.1373/CLINCHEM.2009.135517
P407
P577
2010-02-25T00:00:00Z